{
    "items": "130",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Market Losses Widen; Why Tesla's Slide May Be Bullish",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-losses-broaden-bitcoin-skids-why-teslas-slide-may-be-bullish/",
            "time_published": "20240103T221600",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Market Losses Widen. Why Tesla's Slide May Be Bullish Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/05/Stock-elonmusk-grumpy-01-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": -0.036382,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MARA",
                    "relevance_score": "0.179788",
                    "ticker_sentiment_score": "-0.138269",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.072435",
                    "ticker_sentiment_score": "-0.110765",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSTR",
                    "relevance_score": "0.072435",
                    "ticker_sentiment_score": "-0.01356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.072435",
                    "ticker_sentiment_score": "-0.110765",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.317527",
                    "ticker_sentiment_score": "-0.061006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.036255",
                    "ticker_sentiment_score": "-0.105474",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.138464",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.036255",
                    "ticker_sentiment_score": "-0.152493",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.214937",
                    "ticker_sentiment_score": "-0.038652",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.249653",
                    "ticker_sentiment_score": "-0.140816",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ate too much during the holidays? Now be on guard for the weight-loss scams",
            "url": "https://www.marketwatch.com/story/ate-too-much-during-the-holidays-now-be-on-guard-for-the-weight-loss-scams-e0799b8b",
            "time_published": "20240103T184200",
            "authors": [
                "Lukas I. Alpert"
            ],
            "summary": "Weight-loss drugs like Ozempic and Wegovy have been all the rage lately, but with the holiday season wrapping up, so are weight-loss scams. Experts say now is the time when ads promoting \"miracle\" weight-loss cures start popping up in droves, looking to take advantage of people who have made New ...",
            "banner_image": "https://images.mktw.net/im-815160/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.152881,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.142144",
                    "ticker_sentiment_score": "0.013073",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.142144",
                    "ticker_sentiment_score": "0.013073",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Research Reports for Amazon.com, Berkshire Hathaway & Eli Lilly",
            "url": "https://www.zacks.com/research-daily/2204956/top-research-reports-for-amazoncom-berkshire-hathaway-eli-lilly",
            "time_published": "20240103T173700",
            "authors": [
                "Sheraz Mian"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Eli Lilly and Company (LLY).",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default329.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.269929,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.372257",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.095899",
                    "ticker_sentiment_score": "0.352939",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.095899",
                    "ticker_sentiment_score": "0.107515",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Is Jumping Today While the Overall Market Is Slumping",
            "url": "https://www.fool.com/investing/2024/01/03/why-eli-lilly-stock-is-jumping-today-while-the-ove/",
            "time_published": "20240103T172011",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Here's how the big pharma stock is swimming against the current.",
            "banner_image": "https://g.foolcdn.com/editorial/images/760035/ozempic.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.165653,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.822443",
                    "ticker_sentiment_score": "0.223974",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.108366",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Missed Out on Eli Lilly? My Best Pharmaceutical Stock to Buy And Hold",
            "url": "https://www.fool.com/investing/2024/01/03/missed-out-eli-lilly-best-pharmaceutical-stock/",
            "time_published": "20240103T160850",
            "authors": [
                "Justin Pope"
            ],
            "summary": "The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead.",
            "banner_image": "https://media.ycharts.com/charts/14da68206118d21fd87def9a5d059da6.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                }
            ],
            "overall_sentiment_score": 0.225488,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.592095",
                    "ticker_sentiment_score": "0.308965",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.465196",
                    "ticker_sentiment_score": "0.240351",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Sitting on gains of 1,200% - it would have been irresponsible not to take some profits",
            "url": "https://www.cnbc.com/2024/01/03/sitting-on-gains-of-1200-percent-it-would-have-been-irresponsible-not-to-take-profits.html",
            "time_published": "20240103T160847",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "The Investing Club holds its \"Morning Meeting\" every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107353758-17042961141704296107-32728997393-1080pnbcnews.jpg?v=1704296114&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.22172,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.28008",
                    "ticker_sentiment_score": "0.195968",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.367412",
                    "ticker_sentiment_score": "0.239968",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.367412",
                    "ticker_sentiment_score": "0.239968",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.095138",
                    "ticker_sentiment_score": "0.100694",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "If You Invested $1000 In This Stock 20 Years Ago, You Would Have $9,000 Today - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/24/01/36472515/if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-9-000-today",
            "time_published": "20240103T160027",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly LLY has outperformed the market over the past 20 years by 4.17% on an annualized basis producing an average annual return of 11.54%. Currently, Eli Lilly has a market capitalization of $580.10 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.158543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.980595",
                    "ticker_sentiment_score": "0.375984",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Dow Jones Weakens After Economic Data; Tesla Hits Nasdaq",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-fed-minutes-loom-tesla-hits-nasdaq/",
            "time_published": "20240103T155600",
            "authors": [
                "Investor's Business Daily",
                "VIDYA RAMAKRISHNAN"
            ],
            "summary": "Dow Jones Falls As Fed Minutes Loom. Tesla Hits Nasdaq Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/04/stock-tesla-store-04-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995015"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.016843,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.161207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.063763",
                    "ticker_sentiment_score": "-0.068032",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "-0.110408",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.161207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.251032",
                    "ticker_sentiment_score": "0.007865",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "-0.001233",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "-0.001233",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.25909",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.25909",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LW",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.161207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here is What to Know Beyond Why Eli Lilly and Company  ( LLY )  is a Trending Stock",
            "url": "https://www.zacks.com/stock/news/2204917/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock",
            "time_published": "20240103T140011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default108.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.254969,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.523044",
                    "ticker_sentiment_score": "0.181048",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Techs Skid To Start 2024; Two Weight-Loss Stocks Flash Buy Signals",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-slump-to-start-2024-celsius-eli-lilly-flash-buy-signals/",
            "time_published": "20240102T214700",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Futures: Techs Slump To Start 2024. Celsius, Eli Lilly Flash Buy Signals Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/01/Skifall-EG-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.0584,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.243498",
                    "ticker_sentiment_score": "-0.003766",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CELH",
                    "relevance_score": "0.243498",
                    "ticker_sentiment_score": "0.159344",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.153666",
                    "ticker_sentiment_score": "-0.137704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.030918",
                    "ticker_sentiment_score": "-0.114986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.330152",
                    "ticker_sentiment_score": "-0.057055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.129941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.030918",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "New Year Resolution Stocks: Can Getting Fitter Be A Winner On The Stock Market? - Anheuser-Busch InBev  ( NYSE:BUD ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/entertainment/24/01/36456513/new-year-resolution-stocks-can-getting-fitter-be-a-winner-on-the-stock-market",
            "time_published": "20240102T175811",
            "authors": [
                "Neil Dennis"
            ],
            "summary": "As another holiday season fades into memory, and we return to our desks - perhaps a little flabbier and a little hungover - will investors think about carrying over their New Year resolutions into their stock portfolios?",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Strong-Woman-Exercising-With-Battle-Rope.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.143826,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BUD",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "0.063366",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "0.022267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "0.022267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLNT",
                    "relevance_score": "0.420316",
                    "ticker_sentiment_score": "0.072538",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why This IBD Stock Of The Day Just Struck A Bullish Pose",
            "url": "https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-strikes-a-bullish-pose-after-closing-a-recent-takeover/",
            "time_published": "20240102T170800",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "Eli Lilly Stock Strikes A Bullish Pose After Closing A Recent Takeover Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/SOTD-1-2-2024LLY.png",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.107357,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.677874",
                    "ticker_sentiment_score": "0.0787",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Stock Up 57% in 2023: Will the Uptrend Continue?",
            "url": "https://www.zacks.com/stock/news/2204399/eli-lilly-lly-stock-up-57-in-2023-will-the-uptrend-continue",
            "time_published": "20240102T134300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimer's. Mounjaro and Zepbound are expected to be key top-line drivers for Lilly.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.243868,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.598368",
                    "ticker_sentiment_score": "0.380988",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "RIGL",
                    "relevance_score": "0.203643",
                    "ticker_sentiment_score": "0.133485",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.15347",
                    "ticker_sentiment_score": "0.044317",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AQST",
                    "relevance_score": "0.203643",
                    "ticker_sentiment_score": "0.070763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.051441",
                    "ticker_sentiment_score": "0.033004",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures: Rally Looks Strong As 2024 Kicks Off; What To Do",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-2024-tesla-deliveries-due/",
            "time_published": "20240101T193700",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures: Market Rally Strong Heading Into 2024: Tesla Deliveries Due Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/11/Stock-technologytrends2024-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.106809,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.163117",
                    "ticker_sentiment_score": "0.024947",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XPEV",
                    "relevance_score": "0.07031",
                    "ticker_sentiment_score": "-0.031392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CELH",
                    "relevance_score": "0.18602",
                    "ticker_sentiment_score": "0.016434",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.139106",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.253706",
                    "ticker_sentiment_score": "0.034788",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "0.076734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NIO",
                    "relevance_score": "0.07031",
                    "ticker_sentiment_score": "0.028402",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.163117",
                    "ticker_sentiment_score": "0.064293",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.07031",
                    "ticker_sentiment_score": "-0.025177",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LI",
                    "relevance_score": "0.093653",
                    "ticker_sentiment_score": "-0.015711",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Could Start Off 2024 With a Bang",
            "url": "https://www.fool.com/investing/2024/01/01/why-eli-lilly-could-start-off-2024-with-a-bang/",
            "time_published": "20240101T121500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Investors shouldn't assume Eli Lilly's stock has peaked.",
            "banner_image": "https://g.foolcdn.com/editorial/images/759509/businessperson-giving-a-presentation.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.270091,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.480056",
                    "ticker_sentiment_score": "0.320178",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Is Eli Lilly Investing Up to $494 Million to Study Squirrel Hibernation?",
            "url": "https://www.fool.com/investing/2023/12/31/eli-lilly-investing-to-study-squirrel-hibernation/",
            "time_published": "20231231T140000",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "No squirrels are being harmed, and many people might eventually be helped.",
            "banner_image": "https://g.foolcdn.com/editorial/images/759572/scientist-peers-into-microscope-in-laboratory.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.263641,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.289987",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly Stock Jumped 59% in 2023. Is It a Good Stock to Buy in 2024?",
            "url": "https://www.fool.com/investing/2023/12/31/eli-lilly-stock-jumped-59-in-2023-is-it-a-good-sto/",
            "time_published": "20231231T103600",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Sales of its new weight-management drug could be off the charts next year.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F759654%2Finvestment-advisor-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.279304,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.533678",
                    "ticker_sentiment_score": "0.416847",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.173663",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Gear Up For 2024; Five Big Winners Setting Up Again",
            "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-2024-nvidia-sets-up-after-monster-run-tesla-deliveries-due/",
            "time_published": "20231229T221600",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Stock Market 2024, Here's How To Prep: Nvidia Sets Up After Monster Run. Tesla Deliveries Due Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/11/Stock-technologytrends2024-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.113966,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.178837",
                    "ticker_sentiment_score": "0.026604",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XPEV",
                    "relevance_score": "0.077177",
                    "ticker_sentiment_score": "-0.029516",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CELH",
                    "relevance_score": "0.203857",
                    "ticker_sentiment_score": "0.017617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.25325",
                    "ticker_sentiment_score": "0.149522",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.277576",
                    "ticker_sentiment_score": "0.037403",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.22867",
                    "ticker_sentiment_score": "0.087926",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NIO",
                    "relevance_score": "0.077177",
                    "ticker_sentiment_score": "-0.029516",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.178837",
                    "ticker_sentiment_score": "0.068536",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.077177",
                    "ticker_sentiment_score": "-0.025409",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LI",
                    "relevance_score": "0.128272",
                    "ticker_sentiment_score": "-0.017589",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Unpacking the Latest Options Trading Trends in Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/12/36428493/unpacking-the-latest-options-trading-trends-in-eli-lilly",
            "time_published": "20231229T151557",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.141992,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.655824",
                    "ticker_sentiment_score": "0.03718",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Which Mutual Funds Are Positioned Perfectly For 2024?",
            "url": "https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-are-positioned-perfectly-for-2024/",
            "time_published": "20231229T120000",
            "authors": [
                "Investor's Business Daily",
                "ADAM SHELL"
            ],
            "summary": "Best Mutual Funds: Which Are Positioned Perfectly For 2024? Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-marketBoard-29-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.266261,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ENPH",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.276091",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.143593",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.057444",
                    "ticker_sentiment_score": "0.142039",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.057444",
                    "ticker_sentiment_score": "0.206",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SWK",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.182612",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SWKH",
                    "relevance_score": "0.019163",
                    "ticker_sentiment_score": "0.17269",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "USEG",
                    "relevance_score": "0.019163",
                    "ticker_sentiment_score": "0.116482",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADMA",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.198468",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.1224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DEO",
                    "relevance_score": "0.019163",
                    "ticker_sentiment_score": "0.099371",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.07654",
                    "ticker_sentiment_score": "0.187525",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CECO",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.297189",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ASHTF",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.293549",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.044768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEDG",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.276091",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.143593",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RNR",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.1224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.057444",
                    "ticker_sentiment_score": "0.160299",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.143593",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.044768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.057444",
                    "ticker_sentiment_score": "0.142039",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STLD",
                    "relevance_score": "0.038314",
                    "ticker_sentiment_score": "0.293549",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Stock Declines While Market Improves: Some Information for Investors",
            "url": "https://www.zacks.com/stock/news/2203352/eli-lilly-lly-stock-declines-while-market-improves-some-information-for-investors",
            "time_published": "20231228T224518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The latest trading day saw Eli Lilly (LLY) settling at $580.85, representing a -0.11% change from its previous close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default169.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.220419,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.481177",
                    "ticker_sentiment_score": "0.23999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Fusion Pharmaceuticals  ( FUSN )  Stock Was Up 14% on Wednesday",
            "url": "https://www.zacks.com/stock/news/2203322/why-fusion-pharmaceuticals-fusn-stock-was-up-14-on-wednesday",
            "time_published": "20231228T181100",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Fusion Pharmaceuticals (FUSN) surges to a new record level 52-week high after analysts at Raymond James upgraded its rating following the buyout announcements for two comparable companies.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.254463,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.289748",
                    "ticker_sentiment_score": "0.099799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.074001",
                    "ticker_sentiment_score": "0.048346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FUSN",
                    "relevance_score": "0.806505",
                    "ticker_sentiment_score": "0.457704",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.289748",
                    "ticker_sentiment_score": "0.264795",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.",
            "url": "https://www.fool.com/investing/2023/12/28/interested-in-the-weight-loss-market-heres-1-stock/",
            "time_published": "20231228T133000",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "While Novo Nordisk dominates the weight-loss market, there are two other stocks to consider as well.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F759102%2Fa-doctor-writing-a-prescription.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.249927,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.532043",
                    "ticker_sentiment_score": "0.439982",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "-0.030773",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.19117",
                    "ticker_sentiment_score": "0.124512",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.454714",
                    "ticker_sentiment_score": "0.146467",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts - Abbott Laboratories  ( NYSE:ABT ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/news/23/12/36409451/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-streets-most-accurate-analysts",
            "time_published": "20231228T123313",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/28/image37.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.752319"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.1564,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "C",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.074886",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "-0.044126",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "-0.106435",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "0.17572",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "0.070882",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MGTX",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "0.17572",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky",
            "url": "https://www.marketwatch.com/story/heres-a-solid-contrarian-idea-for-2024-according-to-btigs-krinsky-32a86261",
            "time_published": "20231228T113400",
            "authors": [
                "Jamie Chisholm"
            ],
            "summary": "Investors should consider this list of healthcare stocks for ...",
            "banner_image": "https://images.mktw.net/im-43589352?width=700&height=475",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995973"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.048043,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "EVR",
                    "relevance_score": "0.04076",
                    "ticker_sentiment_score": "-0.041904",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "-0.222027",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.04076",
                    "ticker_sentiment_score": "0.097643",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALKS",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "-0.010447",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NARI",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.121856",
                    "ticker_sentiment_score": "-0.174814",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.043737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMEH",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NTRA",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APGE",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.084543",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLP",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.121856",
                    "ticker_sentiment_score": "-0.092767",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ENSG",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "-0.010447",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FTRE",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "-0.010447",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.04076",
                    "ticker_sentiment_score": "-0.361915",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "BHVN",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.084543",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SHCR",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PGNY",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.043737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IQV",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.043737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SOPH",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ITGR",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "-0.010447",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSTL",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEO",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXEL",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.084543",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LH",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.043737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:JPY",
                    "relevance_score": "0.04076",
                    "ticker_sentiment_score": "0.040214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.081414",
                    "ticker_sentiment_score": "0.104507",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF  ( GSEW )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2202964/should-goldman-sachs-equal-weight-us-large-cap-equity-etf-gsew-be-on-your-investing-radar",
            "time_published": "20231228T112005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default159.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.142688,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.186738",
                    "ticker_sentiment_score": "0.062031",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.125134",
                    "ticker_sentiment_score": "0.057472",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TPL",
                    "relevance_score": "0.125134",
                    "ticker_sentiment_score": "0.057472",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly completes small buy of cancer drugmaker - the payoff may come later",
            "url": "https://www.cnbc.com/2023/12/27/eli-lilly-makes-small-buy-of-cancer-drugmaker-the-payoff-comes-later-.html",
            "time_published": "20231227T200214",
            "authors": [
                "Kevin Stankiewicz"
            ],
            "summary": "Eli Lilly's Point Biopharma acquisition doesn't change our optimism on the diabetes-and-obesity drug giant heading into the new year.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106301321-1576616813818img_1633r.jpg?v=1691536881&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.972756"
                }
            ],
            "overall_sentiment_score": 0.211064,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.413049",
                    "ticker_sentiment_score": "0.247508",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned - Fusion Pharmaceuticals  ( NASDAQ:FUSN ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36400490/recent-m-a-bodes-well-for-targeted-cancer-therapy-player-fusion-pharmaceuticals-ana",
            "time_published": "20231227T174214",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "With recent merger and acquisition deals in the targeted radiopharmaceutical therapy ( TRT ) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc FUSN is potentially the sole remaining clinical-stage player with a robust supply chain.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/27/fusn.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.38899,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.169807",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.354095",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "FUSN",
                    "relevance_score": "0.630923",
                    "ticker_sentiment_score": "0.561656",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.52759",
                    "ticker_sentiment_score": "0.601171",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.354095",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.169807",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The 10 days that moved the stock market the most in 2023",
            "url": "https://www.marketwatch.com/story/the-10-days-that-moved-the-stock-market-the-most-in-2023-611837d9",
            "time_published": "20231227T144300",
            "authors": [
                "William Watts"
            ],
            "summary": "Here are the 5 biggest up days and 5 biggest down days for the S&P 500 this year.",
            "banner_image": "https://images.mktw.net/im-75295800?width=700&height=502",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99393"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.017011,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.035989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.035989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.035989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.155118",
                    "ticker_sentiment_score": "0.110232",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.035989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.117166",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.035989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.117166",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Analysts flag Fusion Pharma as takeover candidate, as stock climbs",
            "url": "https://www.marketwatch.com/story/fusion-pharma-climbs-as-analyst-flags-radiopharmaceutical-company-as-potential-merger-target-e50a6cfa",
            "time_published": "20231227T142800",
            "authors": [
                "Steve Gelsi"
            ],
            "summary": "Targeted-oncology specialist draws upgrade at Raymond James after big premium paid is for Rayze Bio.",
            "banner_image": "https://images.mktw.net/im-722644/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.112776,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PNT",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.042803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.042803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IMGN",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.042803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "0.026053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.042803",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FUSN",
                    "relevance_score": "0.616842",
                    "ticker_sentiment_score": "0.169478",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "0.026053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "0.026053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.042803",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly Completes Acquisition of POINT Biopharma",
            "url": "https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-point-biopharma-302022791.html",
            "time_published": "20231227T133100",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. ( NASDAQ: PNT ) , a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.245623,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.548633",
                    "ticker_sentiment_score": "0.348218",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.168982",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMSQF",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.119836",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.124227",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.09989",
                    "ticker_sentiment_score": "-0.013122",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is SPDR MSCI USA StrategicFactors ETF  ( QUS )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2202432/is-spdr-msci-usa-strategicfactors-etf-qus-a-strong-etf-right-now",
            "time_published": "20231227T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default65.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.195328,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.06109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.06109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.06109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.057767",
                    "ticker_sentiment_score": "0.035965",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bristol-Myers' Acquisition Of Karuna Therapeutics Paves Way For Aggressive Global Marketing Of KarXT: Analyst - Karuna Therapeutics  ( NASDAQ:KRTX ) , Eli Lilly  ( NYSE:LLY ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",
            "url": "https://www.benzinga.com/markets/equities/23/12/36388646/bristol-myers-acquisition-of-karuna-therapeutics-paves-way-for-aggressive-global-marketing-of-ka",
            "time_published": "20231226T190248",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "H.C. Wainwright analyst Raghuram Selvaraju downgraded Karuna Therapeutics, Inc. KRTX to Neutral from Buy, raising the Price Target to $330 from $300. Bristol-Myers Squibb Company BMY agreed to acquire Karuna Therapeutics for $330.00 per share in cash, for a total equity value of $14.0 billion, or ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/26/krtx.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.260319,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.490323",
                    "ticker_sentiment_score": "0.30376",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "0.400572",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "A Closer Look at Eli Lilly's Options Market Dynamics - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/12/36388514/a-closer-look-at-eli-lillys-options-market-dynamics",
            "time_published": "20231226T180043",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 16 unusual trades. Delving into the details, we found 56% of traders were bullish, while 43% showed bearish tendencies.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                }
            ],
            "overall_sentiment_score": 0.098201,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.649352",
                    "ticker_sentiment_score": "0.070795",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Where To Invest Your 401 ( K ) ",
            "url": "https://www.kiplinger.com/retirement/401ks/where-to-invest-your-401k",
            "time_published": "20231225T170013",
            "authors": [
                "Nellie S. Huang"
            ],
            "summary": "These days, 401 ( k ) plans make it relatively easy to save for retirement, but the task of figuring out which funds to invest in is still tricky. A good target-date fund is an easy box to check - and most plans offer one. Low-cost index funds are another no-brainer.",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/zN3tuwiHZ3YvvYxLNgSy2G-415-80.jpg",
            "source": "Kiplinger",
            "category_within_source": "n/a",
            "source_domain": "www.kiplinger.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.247887,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.063258",
                    "ticker_sentiment_score": "0.037124",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.063258",
                    "ticker_sentiment_score": "0.010014",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.042196",
                    "ticker_sentiment_score": "0.047582",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.042196",
                    "ticker_sentiment_score": "0.160021",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.042196",
                    "ticker_sentiment_score": "0.160021",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.042196",
                    "ticker_sentiment_score": "0.160021",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.042196",
                    "ticker_sentiment_score": "-0.005885",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now",
            "url": "https://www.fool.com/investing/2023/12/25/structure-therapeutics-stock-just-crashed-heres/",
            "time_published": "20231225T124500",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "It has genuine struggles ahead, but it has some actual value in hand as well.",
            "banner_image": "https://g.foolcdn.com/editorial/images/758922/stressed-investor-at-laptop.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                }
            ],
            "overall_sentiment_score": 0.127143,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.12023",
                    "ticker_sentiment_score": "0.176753",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.12023",
                    "ticker_sentiment_score": "0.062485",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.040212",
                    "ticker_sentiment_score": "0.011782",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2201872/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar",
            "time_published": "20231225T112008",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default193.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.277959,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TJX",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059923",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Can This Red-Hot Stock Beat the Market Again in 2024?",
            "url": "https://www.fool.com/investing/2023/12/22/can-this-red-hot-stock-beat-the-market-again-2024/",
            "time_published": "20231222T210000",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "I wouldn't bet against it.",
            "banner_image": "https://g.foolcdn.com/editorial/images/758459/physician-shaking-patients-hand.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.262531,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.596532",
                    "ticker_sentiment_score": "0.265499",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Market In Merry Mood Heading Into Christmas: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-rally-is-in-merry-mood-heading-into-christmas-weekend-weekly-review/",
            "time_published": "20231222T173000",
            "authors": [
                "Investor's Business Daily",
                "IBD STAFF"
            ],
            "summary": "The stock market rally suffered a sharp sell-off Wednesday, but the major indexes were flat to slightly higher for the week. Micron Technology ( MU ) jumped on strong earnings and guidance, lifting key chip-gear makers and other semiconductor plays.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/12/Stock-ChristmasTree-NYSE-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.928139"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.123408,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "IMVT",
                    "relevance_score": "0.064161",
                    "ticker_sentiment_score": "-0.170562",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AMAT",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.10249",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRMNF",
                    "relevance_score": "0.021408",
                    "ticker_sentiment_score": "-0.249094",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LPG",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.004971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NISTF",
                    "relevance_score": "0.021408",
                    "ticker_sentiment_score": "-0.027664",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.064161",
                    "ticker_sentiment_score": "0.159217",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TCTZF",
                    "relevance_score": "0.021408",
                    "ticker_sentiment_score": "-0.249094",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NTES",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.265243",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.127908",
                    "ticker_sentiment_score": "-0.099146",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.094598",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.10249",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BILI",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.265243",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.148994",
                    "ticker_sentiment_score": "-0.214209",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AYX",
                    "relevance_score": "0.064161",
                    "ticker_sentiment_score": "0.148185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.064161",
                    "ticker_sentiment_score": "-0.017067",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MU",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "-0.005311",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.169975",
                    "ticker_sentiment_score": "-0.176036",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AIR",
                    "relevance_score": "0.021408",
                    "ticker_sentiment_score": "0.043908",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.130435",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOGL",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.004971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HEI",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.043648",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.15626",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KMX",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.071178",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TGI",
                    "relevance_score": "0.021408",
                    "ticker_sentiment_score": "0.043908",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.148994",
                    "ticker_sentiment_score": "-0.058615",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.094598",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WOR",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.148808",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARGX",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.164222",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CTAS",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.012956",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STNG",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.004971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AFRM",
                    "relevance_score": "0.064161",
                    "ticker_sentiment_score": "0.054092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.055684",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Biotech stocks set for a rebound in 2024, analysts say",
            "url": "https://www.marketwatch.com/story/biotech-stocks-set-for-a-rebound-in-2024-analysts-say-24df6236",
            "time_published": "20231222T160600",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter 2024, analysts say.",
            "banner_image": "https://images.mktw.net/im-15783720/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.133016,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.156557",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRUS",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.080617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KRTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "-0.1576",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "IRON",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.033685",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.17715",
                    "ticker_sentiment_score": "0.070894",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "-0.009465",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VKTX",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.203569",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.085373",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMRN",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "-0.1576",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.111772",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BPMC",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "-0.1576",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.044634",
                    "ticker_sentiment_score": "-0.008934",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These 3 Big Pharma Stocks Are Making Big Plays With AI",
            "url": "https://www.fool.com/investing/2023/12/22/3-big-pharma-stocks-are-making-big-plays-with-ai/",
            "time_published": "20231222T121500",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "Opportunity is in the air with AI, and these pharma giants are seizing the moment.",
            "banner_image": "https://g.foolcdn.com/editorial/images/758794/biotech-pharma-researchers-talk-lab.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.171475,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.207571",
                    "ticker_sentiment_score": "0.149466",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.052455",
                    "ticker_sentiment_score": "-0.026011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABSI",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.099062",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.068798",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.052455",
                    "ticker_sentiment_score": "0.04473",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should iShares MSCI USA Min Vol Factor ETF  ( USMV )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2201371/should-ishares-msci-usa-min-vol-factor-etf-usmv-be-on-your-investing-radar",
            "time_published": "20231222T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.11831,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.050023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127795",
                    "ticker_sentiment_score": "0.068529",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VMW",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.05903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.127795",
                    "ticker_sentiment_score": "0.068529",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
            "url": "https://www.zacks.com/stock/news/2201265/eli-lilly-lly-rises-yet-lags-behind-market-some-facts-worth-knowing",
            "time_published": "20231221T224517",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The latest trading day saw Eli Lilly (LLY) settling at $572, representing a +0.31% change from its previous close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default209.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.185775,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.527969",
                    "ticker_sentiment_score": "0.284696",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stocks Bounce With Inflation Data Due; Six Stocks To Watch",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rebounds-with-key-inflation-data-due-apple-leads-stocks-to-watch/",
            "time_published": "20231221T214800",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Futures: Market Rebounds With Key Inflation Data Due. Apple Leads Stocks To Watch Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.818451"
                }
            ],
            "overall_sentiment_score": 0.13611,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.205308",
                    "ticker_sentiment_score": "0.084713",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.059268",
                    "ticker_sentiment_score": "-0.019059",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.262052",
                    "ticker_sentiment_score": "0.006002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.176502",
                    "ticker_sentiment_score": "0.010328",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMCI",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.069807",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.059268",
                    "ticker_sentiment_score": "0.012047",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MASI",
                    "relevance_score": "0.059268",
                    "ticker_sentiment_score": "0.044035",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.176502",
                    "ticker_sentiment_score": "0.072379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCL",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.004201",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How Is The Market Feeling About Eli Lilly? - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/short-sellers/23/12/36349301/how-is-the-market-feeling-about-eli-lilly",
            "time_published": "20231221T181515",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly's LLY short percent of float has fallen 5.41% since its last report. The company recently reported that it has 5.52 million shares sold short, which is 0.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.15 days to cover their ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.237023,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.081322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Monthly Meeting Q&A with Jim Cramer: Stock buying and selling strategies into year end",
            "url": "https://www.cnbc.com/2023/12/21/monthly-meeting-qa-with-jim-cramer-stock-buying-and-selling-strategies-into-year-end.html",
            "time_published": "20231221T180706",
            "authors": [
                "Paulina Likos"
            ],
            "summary": "During the December Monthly Meeting, we took questions directly from Investing Club members.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107204415-1678206782470-Eaton_Corporation-OB-Photo-MW-20230307-0001-PRESS-1.JPG?v=1678381479&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.769861"
                }
            ],
            "overall_sentiment_score": 0.10348,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HUM",
                    "relevance_score": "0.136666",
                    "ticker_sentiment_score": "0.054069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.058807",
                    "ticker_sentiment_score": "0.043109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VMW",
                    "relevance_score": "0.058807",
                    "ticker_sentiment_score": "0.043109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.058807",
                    "ticker_sentiment_score": "0.043109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NYT",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.044336",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.042455",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.058807",
                    "ticker_sentiment_score": "0.043109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.117295",
                    "ticker_sentiment_score": "0.050055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.019618",
                    "ticker_sentiment_score": "0.039266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.155954",
                    "ticker_sentiment_score": "0.058574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTRA",
                    "relevance_score": "0.058807",
                    "ticker_sentiment_score": "0.043109",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry",
            "url": "https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/",
            "time_published": "20231221T144500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Which weight-loss stocks are good buys today?",
            "banner_image": "https://g.foolcdn.com/editorial/images/758496/a-doctor-looking-at-a-tablet-with-another-person.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.18264,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.290607",
                    "ticker_sentiment_score": "0.215295",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.131126",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.091332",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.290607",
                    "ticker_sentiment_score": "0.215295",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.243864",
                    "ticker_sentiment_score": "0.100877",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Cancer-Focused Biotechs That Appear Promising Bets for 2024",
            "url": "https://www.zacks.com/stock/news/2201005/3-cancer-focused-biotechs-that-appear-promising-bets-for-2024",
            "time_published": "20231221T142300",
            "authors": [
                "Ekta Bagri"
            ],
            "summary": "With the spotlight on oncology-focused companies in the biotech sector in 2023, we discuss three stocks that have a promising oncology portfolio/pipeline for 2024.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.079779,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALLO",
                    "relevance_score": "0.627119",
                    "ticker_sentiment_score": "0.05727",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.094576",
                    "ticker_sentiment_score": "-0.008797",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "-0.008002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BGNE",
                    "relevance_score": "0.187827",
                    "ticker_sentiment_score": "0.159311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TNGX",
                    "relevance_score": "0.187827",
                    "ticker_sentiment_score": "-0.060931",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRTX",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "-0.008002",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?",
            "url": "https://www.investors.com/research/amph-stock-will-eli-lillys-emergency-diabetes-drug-give-amphastar-wings/",
            "time_published": "20231221T130000",
            "authors": [
                "VIDYA RAMAKRISHNAN",
                "Investor's Business Daily"
            ],
            "summary": "Amphastar Pharmaceuticals ( AMPH ) is in a buy zone again after the biotech stock staged a massive 2023 rally. So AMPH stock is Wednesday's pick for IBD 50 Stocks To Watch. According to the IBD MarketSmith pattern recognition tool, AMPH stock sits just above an entry at 58.35 out of a cup with ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/06/Stock-amphastarpharma-01-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999966"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.225237,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.245339",
                    "ticker_sentiment_score": "0.0283",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMPH",
                    "relevance_score": "0.5341",
                    "ticker_sentiment_score": "0.284713",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.082963",
                    "ticker_sentiment_score": "0.147395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FHI",
                    "relevance_score": "0.082963",
                    "ticker_sentiment_score": "0.100143",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Invesco Pharmaceuticals ETF  ( PJP )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2200881/is-invesco-pharmaceuticals-etf-pjp-a-strong-etf-right-now",
            "time_published": "20231221T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default312.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                }
            ],
            "overall_sentiment_score": 0.27378,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.116631",
                    "ticker_sentiment_score": "0.055779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.116631",
                    "ticker_sentiment_score": "0.055779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.174167",
                    "ticker_sentiment_score": "0.245846",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.116631",
                    "ticker_sentiment_score": "0.055779",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?",
            "url": "https://www.marketwatch.com/story/five-obesity-drug-trends-to-watch-in-2024-who-can-compete-with-eli-lilly-and-novo-nordisk-1dc62a7d",
            "time_published": "20231220T161700",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.",
            "banner_image": "https://images.mktw.net/im-80508866/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.119145,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "VKTX",
                    "relevance_score": "0.043778",
                    "ticker_sentiment_score": "0.087169",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.043778",
                    "ticker_sentiment_score": "-0.046832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.087424",
                    "ticker_sentiment_score": "0.081911",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.237288",
                    "ticker_sentiment_score": "0.153064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.043778",
                    "ticker_sentiment_score": "0.083222",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.043778",
                    "ticker_sentiment_score": "-0.018675",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.021897",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.043778",
                    "ticker_sentiment_score": "0.200504",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.065625",
                    "ticker_sentiment_score": "-0.017049",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why - Nestle Malaysia  ( OTC:NSLYF ) , Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) , Nestle  ( OTC:NSRGY ) ",
            "url": "https://www.benzinga.com/markets/equities/23/12/36325784/weight-loss-drugs-by-novo-nordisk-eli-lilly-dont-deter-nestles-coffee-demand-ceo-explains-why",
            "time_published": "20231220T160653",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "Nestle S.A. NSRGY CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's LLY Zepbound and Novo Nordisk's NVO Wegovy, the company has not observed any decrease in coffee consumption.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/20/nestle_coffee_co.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.356024,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HESG",
                    "relevance_score": "0.130926",
                    "ticker_sentiment_score": "0.341705",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "-0.113636",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSRGF",
                    "relevance_score": "0.59016",
                    "ticker_sentiment_score": "0.42816",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "2 Unstoppable Growth Stocks to Buy in 2024",
            "url": "https://www.fool.com/investing/2023/12/20/2-unstoppable-growth-stocks-to-buy-in-2024/",
            "time_published": "20231220T143000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Don't let their valuations scare you off -- these stocks still have more room to rise higher next year.",
            "banner_image": "https://g.foolcdn.com/editorial/images/758495/a-family-meeting-with-an-advisor.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                }
            ],
            "overall_sentiment_score": 0.263013,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.356609",
                    "ticker_sentiment_score": "0.315354",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PDD",
                    "relevance_score": "0.356609",
                    "ticker_sentiment_score": "0.264231",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DG",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "0.087028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DLTR",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "0.087028",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond",
            "url": "https://www.fool.com/investing/2023/12/20/these-2-unstoppable-stocks-could-make-you-richer/",
            "time_published": "20231220T141500",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Eli Lilly and Novo Nordisk are disrupting the weight-loss market with treatments like Mounjaro and Ozempic.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F758466%2Fdoctor-with-senior-man.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.286799,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.440549",
                    "ticker_sentiment_score": "0.362886",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.552001",
                    "ticker_sentiment_score": "0.417987",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "3 Top Dividend Stocks That Recently Hiked Their Payouts",
            "url": "https://www.fool.com/investing/2023/12/20/top-dividend-stocks-recently-hiked-their-payouts/",
            "time_published": "20231220T101000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "These stocks give investors an incentive to buy and hold.",
            "banner_image": "https://g.foolcdn.com/editorial/images/758498/a-couple-reviewing-a-statement.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.376582,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ENB",
                    "relevance_score": "0.381255",
                    "ticker_sentiment_score": "0.369226",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.277748",
                    "ticker_sentiment_score": "0.3916",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "D",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.034022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.113062",
                    "ticker_sentiment_score": "0.152949",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "What the Options Market Tells Us About Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/12/36307677/what-the-options-market-tells-us-about-eli-lilly",
            "time_published": "20231219T160139",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                }
            ],
            "overall_sentiment_score": 0.009604,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.68471",
                    "ticker_sentiment_score": "-0.071665",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK",
            "url": "https://www.zacks.com/stock/news/2199740/the-zacks-analyst-blog-highlights-novo-nordisk-eli-lilly-vertex-pharmaceuticals-regeneron-and-gsk",
            "time_published": "20231219T093400",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK are included in this Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.198286,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.200134",
                    "ticker_sentiment_score": "0.176485",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.067347",
                    "ticker_sentiment_score": "0.08218",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.156316",
                    "ticker_sentiment_score": "0.133696",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.200134",
                    "ticker_sentiment_score": "0.143776",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.022473",
                    "ticker_sentiment_score": "0.021801",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36296151/goldman-sachs-eli-lillys-shares-may-surge-by-140-with-glp-1-drug-boom",
            "time_published": "20231219T050347",
            "authors": [
                "Benzinga Neuro"
            ],
            "summary": "Eli Lilly and Co. LLY could witness a 140% surge in its shares, as predicted by Goldman Sachs. The growth is anticipated to be driven by an increased demand for GLP-1 weight loss and diabetes drugs. What Happened: Goldman Sachs' latest research suggests a bright future for Eli Lilly, as reported ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Basra--Iraq---July-9--2023-Photo-Of-Moun.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.132168,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.531326",
                    "ticker_sentiment_score": "0.072559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.43789",
                    "ticker_sentiment_score": "0.073358",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36287829/obesitydiabetes-drug-class-glp-1s-cost-saving-potential-decoding-impact-on-healthca",
            "time_published": "20231218T193936",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Due to the recent achievements of GLP-1s, Goldman Sachs sees significant potential for Eli Lilly And Co LLY, Novo Nordisk A/S NVO, and other companies to venture into categories that exceed the scope of consideration for most investors at present.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/18/ozempic.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.154855,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.094762",
                    "ticker_sentiment_score": "0.171373",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.240368",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.240368",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/23/12/36283166/heres-how-much-you-would-have-made-owning-eli-lilly-stock-in-the-last-15-years",
            "time_published": "20231218T143023",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly LLY has outperformed the market over the past 15 years by 7.97% on an annualized basis producing an average annual return of 19.95%. Currently, Eli Lilly has a market capitalization of $545.04 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.158543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.980595",
                    "ticker_sentiment_score": "0.375984",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?",
            "url": "https://www.fool.com/investing/2023/12/18/these-are-the-3-hottest-biopharma-trends-of-2024/",
            "time_published": "20231218T141500",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "2024 is going to be a sizzler in the biopharma sector.",
            "banner_image": "https://g.foolcdn.com/editorial/images/758306/business-people-and-doctors-talking-on-a-meeting-in-hospital.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.216785,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.1381",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.04645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.147516",
                    "ticker_sentiment_score": "0.224328",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.147516",
                    "ticker_sentiment_score": "0.051851",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.088711",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RXRX",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.147487",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SDGR",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.147487",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.043511",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.04645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.049424",
                    "ticker_sentiment_score": "0.043511",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "5 Big Drug Stocks That May Continue to Outperform in 2024",
            "url": "https://www.zacks.com/stock/news/2199316/5-big-drug-stocks-that-may-continue-to-outperform-in-2024",
            "time_published": "20231218T135400",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Novo Nordisk (NVO), Eli Lilly (LLY), Vertex Pharmaceuticals (VRTX), Regeneron (REGN) and GSK (GSK) have been performing well this year. These stocks are poised to keep the momentum alive in 2024.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.200783,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.184775",
                    "ticker_sentiment_score": "0.189145",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.046588",
                    "ticker_sentiment_score": "0.141465",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.139131",
                    "ticker_sentiment_score": "0.152648",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.184775",
                    "ticker_sentiment_score": "0.155351",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.023304",
                    "ticker_sentiment_score": "0.021882",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist? - Ginkgo Bioworks Holdings  ( NYSE:DNA ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36281714/as-2023-comes-to-a-close-and-updates-are-expected-from-many-companies-are-these-three-unique-biot",
            "time_published": "20231218T134542",
            "authors": [
                "Meg Flippin"
            ],
            "summary": "Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF ( IBB ) was down 7.5% while the S&P 500 was up more than 14%. But that doesn't mean investors should count them out.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/18/screenshot_2023-12-18_at_7.31.58_pm.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.139724,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.195419",
                    "ticker_sentiment_score": "0.080088",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DNA",
                    "relevance_score": "0.098456",
                    "ticker_sentiment_score": "0.135255",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.098456",
                    "ticker_sentiment_score": "0.214798",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.098456",
                    "ticker_sentiment_score": "0.214798",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023",
            "url": "https://www.prnewswire.com/news-releases/lilly-extends-tender-offer-to-acquire-point-biopharma-to-dec-22-2023-302017457.html",
            "time_published": "20231218T114500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Dec. 18, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares ( \"Shares\" ) of common stock of POINT Biopharma Global Inc. ( NASDAQ: PNT ) , for a purchase ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.999973"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.270864,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.445848",
                    "ticker_sentiment_score": "0.337712",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.033703",
                    "ticker_sentiment_score": "0.165279",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMSQF",
                    "relevance_score": "0.033703",
                    "ticker_sentiment_score": "0.183624",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.067347",
                    "ticker_sentiment_score": "0.064405",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.",
            "url": "https://www.fool.com/investing/2023/12/16/ozempic-zepbound-eli-lilly-stock-better-buy/",
            "time_published": "20231216T105500",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Lilly's weight loss drug appears to be on the way to becoming a megablockbuster.",
            "banner_image": "https://media.ycharts.com/charts/39a01a5a743922aa91d566a6a5310e4b.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.132674,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.513606",
                    "ticker_sentiment_score": "0.204324",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.165409",
                    "ticker_sentiment_score": "0.170712",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Dips More Than Broader Market: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2199019/eli-lilly-lly-dips-more-than-broader-market-what-you-should-know",
            "time_published": "20231215T224513",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) closed at $572.04 in the latest trading session, marking a -0.28% move from the prior day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default203.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.199586,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.606946",
                    "ticker_sentiment_score": "0.258514",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Market Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-rally-surges-to-2023-highs-as-fed-pivots-toward-rate-cuts-weekly-review/",
            "time_published": "20231215T155400",
            "authors": [
                "Investor's Business Daily",
                "IBD STAFF"
            ],
            "summary": "The stock market rally raced higher in a powerful, broad advance as the Federal Reserve signaled it could cut rates three times in 2024. The Dow Jones hit a record high while the S&P 500, Nasdaq composite, S&P MidCap 400 and small-cap Russell 2023 all set 2023 bests. Treasury yields plunged.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/03/LSSECRETS-peak-040221.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.972193"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980716"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.992549"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": -0.065812,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.059935",
                    "ticker_sentiment_score": "0.086",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.029989",
                    "ticker_sentiment_score": "-0.028872",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.119532",
                    "ticker_sentiment_score": "-0.108167",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "-0.007668",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.059935",
                    "ticker_sentiment_score": "-0.441897",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "OXY",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "-0.031906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.119532",
                    "ticker_sentiment_score": "0.106769",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.029989",
                    "ticker_sentiment_score": "0.217562",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LEN",
                    "relevance_score": "0.059935",
                    "ticker_sentiment_score": "-0.003011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.1491",
                    "ticker_sentiment_score": "0.10867",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "0.058147",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.059935",
                    "ticker_sentiment_score": "-0.141007",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.059935",
                    "ticker_sentiment_score": "-0.2386",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More",
            "url": "https://www.zacks.com/stock/news/2198513/pharma-stock-roundup-pfe-issues-weak-2024-view-azn-to-buy-icosavax-more",
            "time_published": "20231215T133400",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938793"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.156532,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.271489",
                    "ticker_sentiment_score": "0.219964",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.079",
                    "ticker_sentiment_score": "-0.064902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.079",
                    "ticker_sentiment_score": "-0.065918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "0.070548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "-0.045716",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ICVX",
                    "relevance_score": "0.157227",
                    "ticker_sentiment_score": "0.105049",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.344606",
                    "ticker_sentiment_score": "0.047034",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is SPDR S&P Pharmaceuticals ETF  ( XPH )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2198396/is-spdr-sp-pharmaceuticals-etf-xph-a-strong-etf-right-now",
            "time_published": "20231215T112003",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default94.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999953"
                }
            ],
            "overall_sentiment_score": 0.208864,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.112797",
                    "ticker_sentiment_score": "0.053966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.05654",
                    "ticker_sentiment_score": "0.065917",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.112797",
                    "ticker_sentiment_score": "0.053966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.112797",
                    "ticker_sentiment_score": "0.053966",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Where Will Eli Lilly Be in 5 Years?",
            "url": "https://www.fool.com/investing/2023/12/15/where-will-eli-lilly-be-in-5years/",
            "time_published": "20231215T111500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "There's a lot of growth still to come for this healthcare behemoth.",
            "banner_image": "https://g.foolcdn.com/editorial/images/757824/businessman-checking-his-phone.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.330525,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.70295",
                    "ticker_sentiment_score": "0.500778",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Ozempic Isn't the Best Weight-Loss Treatment Anymore. Here's Why That Shouldn't Matter to Novo Nordisk Investors.",
            "url": "https://www.fool.com/investing/2023/12/14/ozempic-isnt-the-best-weight-loss-treatment-anymor/",
            "time_published": "20231214T141000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Investors shouldn't be quick to discount Novo Nordisk's long-term potential.",
            "banner_image": "https://g.foolcdn.com/editorial/images/757809/doctor-discussing-a-report-with-people.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.04371,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "-0.067078",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.24289",
                    "ticker_sentiment_score": "0.169559",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.463792",
                    "ticker_sentiment_score": "0.170344",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "American Express, Eli Lilly, Humana And More: CNBC's 'Final Trades' - Cigna Group  ( NYSE:CI ) , American Express  ( NYSE:AXP ) ",
            "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/12/36231441/american-express-eli-lilly-humana-and-more-cnbcs-final-trades",
            "time_published": "20231214T134757",
            "authors": [
                "Avi Kapoor"
            ],
            "summary": "On CNBC's \"Halftime Report Final Trades,\" Sarat Sethi picked American Express Company AXP as he expects much more spending from millennials. American Express CEO Stephen Squeri recently said he is not seeing a slowdown in demand for premium and fee-paying cards.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/14/american_express_amex.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.059809,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.48268",
                    "ticker_sentiment_score": "0.163087",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.612033",
                    "ticker_sentiment_score": "0.088353",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.612033",
                    "ticker_sentiment_score": "0.039866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTS",
                    "relevance_score": "0.170878",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Rise Ahead Of Jobless Claims, Retail Sales",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobless-claims-retail-sales-adobe-dives-on-earnings/",
            "time_published": "20231214T131400",
            "authors": [
                "Investor's Business Daily",
                "SCOTT LEHTONEN"
            ],
            "summary": "Dow Jones Futures Rally Ahead Of Jobless Claims, Retail Sales. Adobe Dives On Earnings Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/02/stock-wallStreet-1-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.095261,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.066784",
                    "ticker_sentiment_score": "0.163675",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.16594",
                    "ticker_sentiment_score": "0.208618",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.230704",
                    "ticker_sentiment_score": "0.084278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.004905",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.033421",
                    "ticker_sentiment_score": "0.10721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.100029",
                    "ticker_sentiment_score": "0.174637",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.195569",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JBL",
                    "relevance_score": "0.100029",
                    "ticker_sentiment_score": "-0.09502",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.068678",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.16594",
                    "ticker_sentiment_score": "-0.256888",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.097526",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "-0.011018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.103756",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.094141",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures: What To Do As Rally Runs",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-market-rally-runs-on-fed-rate-cut-shift/",
            "time_published": "20231214T114200",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures Rise As Market Rally Runs On Fed Rate-Cut Shift. What To Do Now Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/04/stock-Federal-Reserve-06-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.014438,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.146202",
                    "ticker_sentiment_score": "0.025365",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.203582",
                    "ticker_sentiment_score": "-0.006401",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.231884",
                    "ticker_sentiment_score": "0.014447",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DDOG",
                    "relevance_score": "0.259881",
                    "ticker_sentiment_score": "-0.00583",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.203582",
                    "ticker_sentiment_score": "-0.105018",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.088039",
                    "ticker_sentiment_score": "0.122924",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.058759",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "0.029224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.029399",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.088039",
                    "ticker_sentiment_score": "0.089746",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.058759",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the SPDR S&P Pharmaceuticals ETF  ( XPH ) ?",
            "url": "https://www.zacks.com/stock/news/2197719/should-you-invest-in-the-spdr-sp-pharmaceuticals-etf-xph",
            "time_published": "20231214T112002",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default309.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.112693,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.031004",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.059923",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow Hits New High In Fed-Led Rally; Adobe Falls Late",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-hits-record-high-as-fed-sees-three-rate-cuts-markets-bet-on-six-adobe-falls-late/",
            "time_published": "20231213T215300",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Hits Record High As Fed Sees Three Rate Cuts. Markets Bet On Six. Adobe Falls Late Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/04/stock-Federal-Reserve-06-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.016808,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.148915",
                    "ticker_sentiment_score": "0.025646",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.207317",
                    "ticker_sentiment_score": "-0.006493",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.236109",
                    "ticker_sentiment_score": "0.014658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DDOG",
                    "relevance_score": "0.264578",
                    "ticker_sentiment_score": "-0.005916",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.207317",
                    "ticker_sentiment_score": "-0.08465",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.089685",
                    "ticker_sentiment_score": "0.123366",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.05986",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.119383",
                    "ticker_sentiment_score": "0.029449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.029951",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.05986",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Obesity Drugs: Employers Embrace Virtual Healthcare to Manage Surging Costs - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36219440/obesity-drugs-employers-embrace-virtual-healthcare-to-manage-surging-costs",
            "time_published": "20231213T182849",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "U.S. employers grappling with mounting expenses linked to covering obesity drugs like Novo Nordisk A/S's NVO Wegovy and Eli Lilly And Co's LLY Zepbound are increasingly turning to virtual healthcare providers such as Teladoc Health Inc TDOC to administer weight-loss management initiatives.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/13/weight_loss-photo_by_tumisu_from_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.238247,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.223866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FBIN",
                    "relevance_score": "0.223866",
                    "ticker_sentiment_score": "0.37702",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "HLT",
                    "relevance_score": "0.223866",
                    "ticker_sentiment_score": "0.37702",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TDOC",
                    "relevance_score": "0.223866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.223866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.223866",
                    "ticker_sentiment_score": "0.37702",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Nvidia, Disney and Tesla are among 2023's buzziest stocks. Can they continue to sizzle in 2024?",
            "url": "https://www.marketwatch.com/story/nvidia-disney-and-tesla-are-among-2023s-buzziest-stocks-can-they-continue-to-sizzle-in-2024-bcea3881",
            "time_published": "20231213T172800",
            "authors": [
                "",
                "Ciara Linnane",
                "Emily Bary"
            ],
            "summary": "Here's a look at what MarketWatch staffers and readers consider to be 2023's most talked-about stocks - and the key issues that will drive their performances in the year to come.",
            "banner_image": "https://images.mktw.net/im-882031?width=700&height=392",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999976"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.146293,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TGT",
                    "relevance_score": "0.043147",
                    "ticker_sentiment_score": "0.105782",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WW",
                    "relevance_score": "0.043147",
                    "ticker_sentiment_score": "0.146279",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.021581",
                    "ticker_sentiment_score": "0.079279",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.064681",
                    "ticker_sentiment_score": "0.182753",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.171333",
                    "ticker_sentiment_score": "0.13932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAP",
                    "relevance_score": "0.043147",
                    "ticker_sentiment_score": "-0.102156",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.043147",
                    "ticker_sentiment_score": "0.200728",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.107591",
                    "ticker_sentiment_score": "0.038125",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BUD",
                    "relevance_score": "0.043147",
                    "ticker_sentiment_score": "-0.041962",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.086167",
                    "ticker_sentiment_score": "0.089536",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.128937",
                    "ticker_sentiment_score": "0.067554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.043147",
                    "ticker_sentiment_score": "0.021957",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.064681",
                    "ticker_sentiment_score": "0.203605",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GME",
                    "relevance_score": "0.086167",
                    "ticker_sentiment_score": "0.092222",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What Are The Best Stocks To Invest In Now? 2 Health Care Stocks To Watch",
            "url": "https://stockmarket.com/featured/what-are-the-best-stocks-to-invest-in-now-2-health-care-stocks-to-watch-2023-12-13",
            "time_published": "20231213T162958",
            "authors": [
                "Jonathan Phillip"
            ],
            "summary": "The healthcare sector encompasses a wide range of companies involved in medical services, pharmaceuticals, medical equipment, and health insurance. This sector is essential due to its direct impact on human health and well-being.",
            "banner_image": "https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2020/12/LLY-stock.jpg",
            "source": "StockMarket.com",
            "category_within_source": "n/a",
            "source_domain": "stockmarket.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999982"
                }
            ],
            "overall_sentiment_score": 0.197958,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.461006",
                    "ticker_sentiment_score": "0.266389",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.081552",
                    "ticker_sentiment_score": "0.101044",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know",
            "url": "https://www.zacks.com/stock/news/2197261/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know",
            "time_published": "20231213T140010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default99.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.215098,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.523995",
                    "ticker_sentiment_score": "0.156507",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Futures Rise Ahead Of Inflation Data; Fed, Powell Up Next",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-key-inflation-data-fed-decision-powell-up-next/",
            "time_published": "20231213T132200",
            "authors": [
                "SCOTT LEHTONEN",
                "Investor's Business Daily"
            ],
            "summary": "Futures Rise Ahead Of Inflation Data. Fed, Powell Up Next Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-04-gov.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.126334,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.093653",
                    "ticker_sentiment_score": "0.078073",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.155451",
                    "ticker_sentiment_score": "0.091632",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REVG",
                    "relevance_score": "0.031282",
                    "ticker_sentiment_score": "0.180072",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.216307",
                    "ticker_sentiment_score": "0.080087",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.124647",
                    "ticker_sentiment_score": "-0.030923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.031282",
                    "ticker_sentiment_score": "0.106228",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.093653",
                    "ticker_sentiment_score": "0.078073",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.216307",
                    "ticker_sentiment_score": "0.063004",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.124647",
                    "ticker_sentiment_score": "0.038451",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.062515",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.124647",
                    "ticker_sentiment_score": "0.06378",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLAB",
                    "relevance_score": "0.031282",
                    "ticker_sentiment_score": "0.180072",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.155451",
                    "ticker_sentiment_score": "0.020143",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.124647",
                    "ticker_sentiment_score": "0.1322",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.124647",
                    "ticker_sentiment_score": "0.054571",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "LifeMD's stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs",
            "url": "https://www.marketwatch.com/story/lifemds-stock-soars-9-5-on-news-company-is-teaming-up-with-medifast-to-create-weight-management-program-that-includes-glp-1-drugs-55f94875",
            "time_published": "20231213T130400",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "Medifast is scrapping its quarterly dividend to invest instead in a partnership with LifeMD and other growth initiatives.",
            "banner_image": "https://images.mktw.net/im-793547/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.316562,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "-0.071206",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LFMD",
                    "relevance_score": "0.490323",
                    "ticker_sentiment_score": "0.406103",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MED",
                    "relevance_score": "0.490323",
                    "ticker_sentiment_score": "0.459716",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "-0.071206",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight Loss Drugs' Trickle Down Effect - Insurer Restrictions Create Access Challenges For Diabetes Patients - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36201549/weight-loss-drugs-trickle-down-effect-insurer-restrictions-create-access-challenges-for-diabetes-",
            "time_published": "20231212T185330",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "There is growing concern among some type 2 diabetes patients over challenges in obtaining reimbursement for medications like Novo Nordisk A/S's NVO Ozempic amid stricter health plan management by U.S. insurers.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/12/ozempic.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.081518,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.250386",
                    "ticker_sentiment_score": "-0.125536",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.250386",
                    "ticker_sentiment_score": "0.061569",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "LLY Down as Patients Regain Weight After Stopping Zepbound",
            "url": "https://www.zacks.com/stock/news/2196988/lly-down-as-patients-regain-weight-after-stopping-zepbound",
            "time_published": "20231212T181900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Full results from a late-stage study show that patients who stopped taking Eli Lilly's (LLY) weight-loss drug for over a year slowly started to regain their lost weight.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.155041,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.199782",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.266828",
                    "ticker_sentiment_score": "0.222446",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.266828",
                    "ticker_sentiment_score": "0.30101",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's why Eaton could be our next play after exiting Oracle",
            "url": "https://www.cnbc.com/2023/12/12/heres-why-eaton-could-be-our-next-play-after-exiting-oracle-.html",
            "time_published": "20231212T160740",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107346448-17023959171702395913-32422662783-1080pnbcnews.jpg?v=1702395917&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.077053,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.229872",
                    "ticker_sentiment_score": "0.058",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ETN",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.043283",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?",
            "url": "https://www.fool.com/investing/2023/12/12/better-growth-stock-viking-therapeutics-or-iovance/",
            "time_published": "20231212T134500",
            "authors": [
                "George Budwell"
            ],
            "summary": "Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757942%2Fgrowth-stock.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.143186,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "0.120006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VKTX",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.050158",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOVA",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.050158",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "0.17028",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "0.120006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "0.17028",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:GBP",
                    "relevance_score": "0.060388",
                    "ticker_sentiment_score": "-0.073154",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Rise Ahead Of CPI Inflation Report",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-cpi-inflation-report-ai-giant-oracle-dives-on-earnings/",
            "time_published": "20231212T131500",
            "authors": [
                "SCOTT LEHTONEN",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones futures rose modestly Tuesday morning ahead of a critical inflation report, while other major indexes came along for the ride. Meanwhile, artificial intelligence player Oracle ( ORCL ) took a dive after reporting weak sales results. The Labor Department's Consumer Price Index is due ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/03/stock-wallstreet-031317-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.144773,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.104835",
                    "ticker_sentiment_score": "0.129742",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.241512",
                    "ticker_sentiment_score": "0.026101",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.104835",
                    "ticker_sentiment_score": "-0.068395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.035035",
                    "ticker_sentiment_score": "0.058375",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.035035",
                    "ticker_sentiment_score": "0.107903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.149251",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.104835",
                    "ticker_sentiment_score": "0.129742",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.147157",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.040733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.067645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CASY",
                    "relevance_score": "0.104835",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.173832",
                    "ticker_sentiment_score": "-0.011533",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.07295",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.092766",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Weight Loss Stock: Eli Lilly or Novo Nordisk?",
            "url": "https://www.fool.com/investing/2023/12/12/better-weight-loss-stock-eli-lilly-or-novo-nordisk/",
            "time_published": "20231212T123000",
            "authors": [
                "George Budwell"
            ],
            "summary": "Both of these pharma stocks have been top performers in 2023. One stock is the better long-term buy, however.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757950%2Fgrowth-trend.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                }
            ],
            "overall_sentiment_score": 0.223546,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.457274",
                    "ticker_sentiment_score": "0.31369",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.138066",
                    "ticker_sentiment_score": "0.338499",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Futures: Magnificent 7 Stocks Slide; CPI Next",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-magnificent-seven-stocks-slide-ai-giant-oracle-dives-on-earnings-cpi-next/",
            "time_published": "20231211T223300",
            "authors": [
                "Investor's Business Daily",
                "SCOTT LEHTONEN"
            ],
            "summary": "Dow Jones Futures: Magnificent Seven Stocks Slide. AI Giant Oracle Dives On Earnings. CPI Next Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-inflation-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.146548,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.075279",
                    "ticker_sentiment_score": "0.021662",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.112709",
                    "ticker_sentiment_score": "0.009323",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.112709",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.223179",
                    "ticker_sentiment_score": "0.024582",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.075279",
                    "ticker_sentiment_score": "-0.105053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.037681",
                    "ticker_sentiment_score": "0.072953",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.112709",
                    "ticker_sentiment_score": "0.149903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.112709",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.259135",
                    "ticker_sentiment_score": "0.136515",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEN",
                    "relevance_score": "0.075279",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.149889",
                    "ticker_sentiment_score": "0.042501",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.075279",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.149889",
                    "ticker_sentiment_score": "0.105591",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DRI",
                    "relevance_score": "0.075279",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.186738",
                    "ticker_sentiment_score": "-0.01213",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.186738",
                    "ticker_sentiment_score": "0.06518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.149889",
                    "ticker_sentiment_score": "0.048804",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly Weighs On Novo After Unveiling A New Finding For Obesity Drugs",
            "url": "https://www.investors.com/news/technology/eli-lilly-stock-slumps-as-a-new-study-highlights-the-impact-of-stopping-weight-loss-drug/",
            "time_published": "20231211T170400",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "Eli Lilly Stock Slumps As A New Study Highlights The Impact Of Stopping Weight-Loss Drug Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-Lab01-company.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                }
            ],
            "overall_sentiment_score": 0.007233,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.434514",
                    "ticker_sentiment_score": "0.07433",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.181819",
                    "ticker_sentiment_score": "-0.131405",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Stock Is Tumbling Today - Here's Why - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36180114/eli-lilly-stock-is-tumbling-today-heres-why",
            "time_published": "20231211T170243",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY announced the detailed results from the SURMOUNT-4 Phase 3 study evaluating the safety and efficacy of Zepbound ( tirzepatide ) compared to a placebo for obesity with weight-related comorbidities, excluding type 2 diabetes.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/11/eli_lilly_corporate_center_indianapolis_indiana_usa.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.007132,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.47672",
                    "ticker_sentiment_score": "0.269162",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Futures Dip; Apple Headlines 9 Stocks To Buy And Watch",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-apple-stock-headlines-best-stocks-to-buy-and-watch/",
            "time_published": "20231211T131600",
            "authors": [
                "Investor's Business Daily",
                "SCOTT LEHTONEN"
            ],
            "summary": "Futures Dip. Apple Headlines 9 Stocks To Buy And Watch Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/09/Stock-wallstreetflag-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.151691,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.10607",
                    "ticker_sentiment_score": "0.090263",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.166199",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "0.099783",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.07083",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.07083",
                    "ticker_sentiment_score": "0.255099",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.03545",
                    "ticker_sentiment_score": "0.030263",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "0.121311",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.11143",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "0.102936",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEN",
                    "relevance_score": "0.07083",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "0.039736",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.07083",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "0.098099",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DRI",
                    "relevance_score": "0.07083",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NET",
                    "relevance_score": "0.03545",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "-0.080916",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.141102",
                    "ticker_sentiment_score": "0.036687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.215322",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?",
            "url": "https://www.zacks.com/stock/news/2195941/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe",
            "time_published": "20231211T112007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default127.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.163989,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.067158",
                    "ticker_sentiment_score": "0.032048",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.061752",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.043607",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.061752",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?",
            "url": "https://www.zacks.com/stock/news/2195947/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc",
            "time_published": "20231211T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default274.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.310406,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.128135",
                    "ticker_sentiment_score": "0.049945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.128135",
                    "ticker_sentiment_score": "0.049945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.128135",
                    "ticker_sentiment_score": "0.049945",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Unstoppable Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2023/12/10/3-unstoppable-stocks-to-buy-right-now/",
            "time_published": "20231210T115600",
            "authors": [
                "Keith Speights",
                "David Jagielski",
                "and Prosper Junior Bakiny"
            ],
            "summary": "These stocks could be just the ticket for investors seeking strong growth.",
            "banner_image": "https://g.foolcdn.com/editorial/images/757538/two-people-with-ipad-and-laptop.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99393"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.265592,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.411176",
                    "ticker_sentiment_score": "0.233842",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.171181",
                    "ticker_sentiment_score": "0.189008",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "0.134502",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JAZZ",
                    "relevance_score": "0.043108",
                    "ticker_sentiment_score": "-0.011888",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXSM",
                    "relevance_score": "0.171181",
                    "ticker_sentiment_score": "0.154166",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Rises Higher Than Market: Key Facts",
            "url": "https://www.zacks.com/stock/news/2195769/eli-lilly-lly-rises-higher-than-market-key-facts",
            "time_published": "20231208T224512",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.215981,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.675573",
                    "ticker_sentiment_score": "0.384319",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them' - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36161067/bernie-sanders-to-take-on-ozempic-wegovy-weight-loss-drugs-could-be-helpful-but-theyre-not-going-",
            "time_published": "20231208T210741",
            "authors": [
                "Chris Katje"
            ],
            "summary": "Congressman Bernie Sanders ( I-Vt. ) has been known to tussle with public companies over their high prices or anticompetitive behavior, including pharmaceutical companies and their high costs. In his newest battle, Sanders is taking on the growing popularity of weight-loss drugs and diabetes ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/BernieSanders-Ozempic-Shutterstock.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.089381,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.214937",
                    "ticker_sentiment_score": "0.010354",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.198951",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.28387",
                    "ticker_sentiment_score": "-0.081186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.027719",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pharma Giant Eli Lilly's Shareholder Bonanza: Announces Hefty 15% Dividend Hike For Q1 - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/equities/23/12/36156535/pharma-giant-eli-lillys-shareholder-bonanza-announces-hefty-15-dividend-hike-for-q1",
            "time_published": "20231208T171816",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "Eli Lilly and Company LLY has boosted its quarterly dividend by an impressive 15%, announcing a payout of $1.30 per share for the first quarter of 2024, signaling strong financial confidence. The dividend is payable on March 8, 2024, to shareholders of record at the close of business on February ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/08/lly_co.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.162993,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.729067",
                    "ticker_sentiment_score": "0.675183",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Lilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend",
            "url": "https://www.prnewswire.com/news-releases/lilly-announces-15-dividend-increase-first-quarter-2024-dividend-302010271.html",
            "time_published": "20231208T162500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Dec. 8, 2023 /PRNewswire/ -- The board of directors of Eli Lilly and Company ( NYSE: LLY ) has announced a 15% increase in its quarterly dividend and declared a dividend for the first quarter of 2024 of $1.30 per share on outstanding common stock.",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                }
            ],
            "overall_sentiment_score": 0.229805,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.491255",
                    "ticker_sentiment_score": "0.336932",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod",
            "url": "https://www.zacks.com/stock/news/2195315/pharma-stock-roundup-abbv-to-buy-cere-jnjs-2024-view-lly-nvs-get-fda-nod",
            "time_published": "20231208T131200",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.095039,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.069294",
                    "ticker_sentiment_score": "0.004039",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CERE",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.080373",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.172097",
                    "ticker_sentiment_score": "0.071082",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.205807",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Lower Ahead Of Imminent Jobs Report",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-imminent-jobs-report-lulu-stock-tumbles-on-earnings/",
            "time_published": "20231208T131100",
            "authors": [
                "SCOTT LEHTONEN",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Futures Fall Ahead Of Imminent Jobs Report. LULU Stock Tumbles On Earnings Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/08/WallStreetFinance-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.116378,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.110632",
                    "ticker_sentiment_score": "0.127159",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.073886",
                    "ticker_sentiment_score": "0.116277",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.036983",
                    "ticker_sentiment_score": "0.008865",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "0.15667",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "0.145716",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "-0.182264",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.110632",
                    "ticker_sentiment_score": "0.127159",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RH",
                    "relevance_score": "0.036983",
                    "ticker_sentiment_score": "-0.115744",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "0.079078",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "0.075151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "0.126032",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NET",
                    "relevance_score": "0.036983",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.183337",
                    "ticker_sentiment_score": "-0.083549",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DOCU",
                    "relevance_score": "0.036983",
                    "ticker_sentiment_score": "-0.115744",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.147141",
                    "ticker_sentiment_score": "0.071416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.183337",
                    "ticker_sentiment_score": "0.110386",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?",
            "url": "https://www.fool.com/investing/2023/12/08/could-lilly-beat-novo-nordisk-in-weight-loss/",
            "time_published": "20231208T103000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These drugs address a rapidly growing market.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757481%2Fgettyimages-1292931102.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.156735,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.052685",
                    "ticker_sentiment_score": "0.15863",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.491255",
                    "ticker_sentiment_score": "0.187817",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.356317",
                    "ticker_sentiment_score": "0.135845",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG",
            "url": "https://www.zacks.com/stock/news/2195206/zacks-market-edge-highlights-saic-anet-lly-pfe-and-sig",
            "time_published": "20231208T083500",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "SAIC, ANET, LLY, PFE and SIG have been highlighted in this Market Edge article.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.972756"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.019138,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.328236",
                    "ticker_sentiment_score": "-0.057021",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIG",
                    "relevance_score": "0.200688",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.446966",
                    "ticker_sentiment_score": "-0.104395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.05663",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.446966",
                    "ticker_sentiment_score": "-0.275549",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SAIC",
                    "relevance_score": "0.502207",
                    "ticker_sentiment_score": "0.083988",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Altimmune's stock pops as analysts see obesity-drug partnership potential",
            "url": "https://www.marketwatch.com/story/altimmune-shares-pop-as-analysts-see-obesity-drug-partnership-potential-524ea4f4",
            "time_published": "20231207T173300",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Altimmune shares have jumped this week as analysts see potential for the company to find a partner for its experimental weight-loss drug.",
            "banner_image": "https://images.mktw.net/im-520633/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.12606,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "EVR",
                    "relevance_score": "0.09439",
                    "ticker_sentiment_score": "-0.093546",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.187463",
                    "ticker_sentiment_score": "0.055818",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.187463",
                    "ticker_sentiment_score": "0.055818",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.187463",
                    "ticker_sentiment_score": "0.055818",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.593484",
                    "ticker_sentiment_score": "0.244327",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.09439",
                    "ticker_sentiment_score": "0.199794",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.187463",
                    "ticker_sentiment_score": "0.023005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Will There Be a Recession in 2024?",
            "url": "https://www.zacks.com/stock/news/2195010/will-there-be-a-recession-in-2024",
            "time_published": "20231207T165800",
            "authors": [
                "Tracey Ryniec"
            ],
            "summary": "Tracey Ryniec and John Blank examine whether a recession is looming and how to invest in the new year.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/40864.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.004799,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.359707",
                    "ticker_sentiment_score": "-0.061115",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIG",
                    "relevance_score": "0.220809",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.487021",
                    "ticker_sentiment_score": "-0.110238",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.057267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.487021",
                    "ticker_sentiment_score": "-0.290289",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SAIC",
                    "relevance_score": "0.545337",
                    "ticker_sentiment_score": "0.088259",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?",
            "url": "https://www.fool.com/investing/2023/12/07/better-large-cap-growth-fund-schwab-us-large-cap-g/",
            "time_published": "20231207T134500",
            "authors": [
                "George Budwell"
            ],
            "summary": "Which of these top-performing growth funds is the better buy?",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F757401%2Fgrowth-trend.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.251414,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.184834",
                    "ticker_sentiment_score": "0.04941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.19115",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.19115",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.19115",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.19115",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Buy Eli Lilly Stock Now or Wait for a Dip?",
            "url": "https://www.fool.com/investing/2023/12/07/should-you-buy-eli-lilly-stock-now-or-wait-for-a/",
            "time_published": "20231207T133000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Eli Lilly's P/E ratio of more than 100 looks steep, but the company is on the cusp of further huge growth.",
            "banner_image": "https://media.ycharts.com/charts/6499460126ec73f86fcde80468338c03.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.723405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                }
            ],
            "overall_sentiment_score": 0.206619,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.570165",
                    "ticker_sentiment_score": "0.280983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.062926",
                    "ticker_sentiment_score": "0.219737",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.062926",
                    "ticker_sentiment_score": "0.219737",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stocks Mixed Ahead Of Jobless Claims",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-jobless-claims-ai-stock-c3-ai-plunges-on-earnings/",
            "time_published": "20231207T132000",
            "authors": [
                "Investor's Business Daily",
                "SCOTT LEHTONEN"
            ],
            "summary": "Dow Jones Futures Fall Ahead Of Jobless Claims. C3.ai Plunges On Earnings Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/10/stock-wall-street-flags-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.104997,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.109789",
                    "ticker_sentiment_score": "0.133047",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.152446",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VEEV",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "-0.043702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.10467",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.202868",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.152446",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.109789",
                    "ticker_sentiment_score": "0.133047",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.078722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.109789",
                    "ticker_sentiment_score": "0.063403",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.125469",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NET",
                    "relevance_score": "0.181956",
                    "ticker_sentiment_score": "0.079084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.025052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GME",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "-0.043702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.181956",
                    "ticker_sentiment_score": "0.108302",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?",
            "url": "https://www.fool.com/investing/2023/12/07/which-stock-is-more-likely-to-help-you-retire-as-a/",
            "time_published": "20231207T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "There's no guarantee that either of these big pharma stocks can help you retire as a millionaire. But one has a clear edge.",
            "banner_image": "https://g.foolcdn.com/editorial/images/757225/man-with-arms-behind-head-looking-at-laptop.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.297769,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.642329",
                    "ticker_sentiment_score": "0.56052",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.056407",
                    "ticker_sentiment_score": "0.248",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.47574",
                    "ticker_sentiment_score": "0.513515",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Walmart seems to have changed its view of weight-loss drugs",
            "url": "https://www.marketwatch.com/story/walmart-seems-to-have-changed-its-view-of-weight-loss-drugs-366d440a",
            "time_published": "20231206T191300",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "In October, the head of Walmart's U.S. business head has said the drugs were already causing customers to buy fewer groceries and cut back on those that are high in calories.",
            "banner_image": "https://images.mktw.net/im-354422/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.0,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GIS",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "-0.170355",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "-0.029478",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.174794",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.174794",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "-0.170355",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "K",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.188928",
                    "ticker_sentiment_score": "0.056142",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36114393/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities",
            "time_published": "20231206T162336",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Johnson & Johnson JNJ has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer Joaquin Duato highlighted. During the firm's investor day on Tuesday, Duato emphasized that the company's priorities lie in extensive expansion, ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/06/jnjioffice3.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.08561,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.27432",
                    "ticker_sentiment_score": "0.164786",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.27432",
                    "ticker_sentiment_score": "0.337197",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.27432",
                    "ticker_sentiment_score": "0.164786",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.27432",
                    "ticker_sentiment_score": "-0.148264",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.401331",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly's Options Frenzy: What You Need to Know - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/12/36115004/eli-lillys-options-frenzy-what-you-need-to-know",
            "time_published": "20231206T153145",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Investors with a lot of money to spend have taken a bearish stance on Eli Lilly LLY. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.102355,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.694939",
                    "ticker_sentiment_score": "0.022921",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Jim Cramer says buy P&G, Starbucks on unwarranted pullbacks",
            "url": "https://www.cnbc.com/2023/12/05/jim-cramer-says-buy-pg-starbucks-on-unwarranted-pullbacks-.html",
            "time_published": "20231205T160405",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107343288-17017905731701790568-32322123565-1080pnbcnews.jpg?v=1701790573&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.98396"
                }
            ],
            "overall_sentiment_score": 0.17601,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.17875",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.255641",
                    "ticker_sentiment_score": "0.144574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.255641",
                    "ticker_sentiment_score": "0.144574",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Zepbound™  ( tirzepatide )  is Now Available in U.S. Pharmacies for Adults Living with Obesity",
            "url": "https://www.prnewswire.com/news-releases/zepbound-tirzepatide-is-now-available-in-us-pharmacies-for-adults-living-with-obesity-302006027.html",
            "time_published": "20231205T123800",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Dec. 5, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced that Zepbound™ ( tirzepatide ) injection is now available.",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.084912,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.195182",
                    "ticker_sentiment_score": "0.091723",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.019715",
                    "ticker_sentiment_score": "0.156024",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.039418",
                    "ticker_sentiment_score": "0.04747",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is it a Good Idea to Invest in AC Immune  ( ACIU )  Stock Now?",
            "url": "https://www.zacks.com/stock/news/2193345/is-it-a-good-idea-to-invest-in-ac-immune-aciu-stock-now",
            "time_published": "20231205T105900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Here, we discuss some reasons why investing in AC Immune (ACIU) stock now may turn out to be a prudent move.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.9545"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.162188,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ACIU",
                    "relevance_score": "0.472959",
                    "ticker_sentiment_score": "0.172325",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.213674",
                    "ticker_sentiment_score": "0.050324",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTMX",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.14456",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "No more exercising? President RFK Jr.? Here's one bank's outrageous predictions for 2024",
            "url": "https://www.marketwatch.com/story/no-more-exercising-president-rfk-jr-heres-one-banks-outrageous-predictions-for-2024-1bc90579",
            "time_published": "20231205T104500",
            "authors": [
                "Steve Goldstein"
            ],
            "summary": "Denmark's Saxo Bank makes a tradition of making \"outrageous predictions,\" which every once in a while comes true ...",
            "banner_image": "https://images.mktw.net/im-23070502/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": -0.089195,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.162255",
                    "ticker_sentiment_score": "0.053536",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.162255",
                    "ticker_sentiment_score": "0.053536",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:JPY",
                    "relevance_score": "0.081552",
                    "ticker_sentiment_score": "0.011316",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/23/12/36083857/jim-cramer-highlights-transformational-impact-of-weight-loss-drugs-like-ozempic-focus-now-on-potenti",
            "time_published": "20231205T012432",
            "authors": [
                "Benzinga Neuro"
            ],
            "summary": "What Happened: Jim Cramer outlined fresh investment prospects on Monday, revolving around the growing demand for GLP-1 drugs, typically administered for diabetes and obesity treatment. As reported by CNBC, investors initially expressed concerns about these drugs' market impact.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Jim-Cramer-Photo-by-s-bukley-on-Shutters_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.321611,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.356865",
                    "ticker_sentiment_score": "0.359113",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "J",
                    "relevance_score": "0.092213",
                    "ticker_sentiment_score": "0.172399",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HRL",
                    "relevance_score": "0.092213",
                    "ticker_sentiment_score": "0.172399",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.356865",
                    "ticker_sentiment_score": "0.359113",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TSN",
                    "relevance_score": "0.092213",
                    "ticker_sentiment_score": "0.172399",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market - Tema Cardiovascular and Metabolic ETF  ( NASDAQ:HRTS ) , Altimmune  ( NASDAQ:ALT ) ",
            "url": "https://www.benzinga.com/markets/equities/23/12/36079945/roche-pfizer-race-to-find-next-ozempic-as-pharma-giants-hustle-to-join-obesity-treatment-market",
            "time_published": "20231204T212012",
            "authors": [
                "Neil Dennis"
            ],
            "summary": "How important it is to have the latest blockbuster in your product portfolio. The pharmaceuticals industry has displayed this over and again in recent years - getting a Covid vaccine to market during the pandemic, and now tackling the obesity epidemic.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/weight-loss-shutter2.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                }
            ],
            "overall_sentiment_score": 0.072139,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.267128",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.318897",
                    "ticker_sentiment_score": "-0.004677",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal",
            "url": "https://www.investors.com/research/ibd-stock-of-the-day/amphastar-amph-stock-breaks-out-as-it-sees-upside-from-eli-lilly-deal/",
            "time_published": "20231204T200200",
            "authors": [
                "Investor's Business Daily",
                "JED GRAHAM"
            ],
            "summary": "Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/12/AMPH.png",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996023"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.212475,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAC",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.075344",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.522333",
                    "ticker_sentiment_score": "0.311976",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMPH",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.246756",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "What the Options Market Tells Us About Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/12/36076107/what-the-options-market-tells-us-about-eli-lilly",
            "time_published": "20231204T184539",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 47 unusual trades. Delving into the details, we found 40% of traders were bullish, while 59% showed bearish tendencies.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.052881,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.703874",
                    "ticker_sentiment_score": "-0.181689",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Are Magnificent Seven Stocks Due For Santa Rally Or Lump of Coal?",
            "url": "https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/magnificent-seven-stocks-nvidia-microsoft-meta-amazon-outlook-santa-rally-or-lump-of-coal/",
            "time_published": "20231204T180800",
            "authors": [
                "MATTHEW GALGANI",
                "Investor's Business Daily"
            ],
            "summary": "IBD Leaderboard showcases Magnificent Seven stocks Nvidia ( NVDA ) , Meta Platforms ( META ) , Microsoft ( MSFT ) and Amazon.com ( AMZN ) , as well as Shopify ( SHOP ) and new S&P 500 member Uber Technologies ( UBER ) .",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/12/Stock-questionmarkpresent-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.206129,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.470894",
                    "ticker_sentiment_score": "0.236647",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SHOP",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.311926",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.299541",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.598621",
                    "ticker_sentiment_score": "0.247405",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.083541",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRS",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ARM",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.301302",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "0.301302",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.246999",
                    "ticker_sentiment_score": "0.301279",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.470894",
                    "ticker_sentiment_score": "0.303114",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly  ( LLY )  Gets Second FDA Nod for Lymphoma Drug Jaypirca",
            "url": "https://www.zacks.com/stock/news/2193151/lilly-lly-gets-second-fda-nod-for-lymphoma-drug-jaypirca",
            "time_published": "20231204T171900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Following the latest approval, Lilly's (LLY) Jaypirca is the first and the only non-covalent BTK inhibitor to extend the benefit of targeting the BTK pathway.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.106483,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.591449",
                    "ticker_sentiment_score": "0.228092",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.380012",
                    "ticker_sentiment_score": "0.153731",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BGNE",
                    "relevance_score": "0.065866",
                    "ticker_sentiment_score": "0.080525",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.131284",
                    "ticker_sentiment_score": "0.087912",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Altimmune  ( ALT )  Rises 83% on Successful Phase II Obesity Study",
            "url": "https://www.zacks.com/stock/news/2193078/altimmune-alt-rises-83-on-successful-phase-ii-obesity-study",
            "time_published": "20231204T163700",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Altimmune (ALT) reports positive top-line data from its 48-week phase II MOMENTUM study of obesity drug candidate, pemvidutide. The stock gains 83%.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c8/39674.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.093656,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.177802",
                    "ticker_sentiment_score": "0.191896",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.346884",
                    "ticker_sentiment_score": "-0.082228",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.221212",
                    "ticker_sentiment_score": "0.1681",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.177802",
                    "ticker_sentiment_score": "0.03385",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "1 Monster Dividend Stock Growth Investors Should Load Up On Right Now",
            "url": "https://www.fool.com/investing/2023/12/04/1-monster-dividend-stock-growth-investors-should-l/",
            "time_published": "20231204T140000",
            "authors": [
                "George Budwell"
            ],
            "summary": "This dividend-paying pharma stock is on a roll.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756997%2Fdividends.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.291513,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.50746",
                    "ticker_sentiment_score": "0.408967",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.",
            "url": "https://www.fool.com/investing/2023/12/04/you-dont-have-to-pick-a-winner-in-gene-editing-do/",
            "time_published": "20231204T133000",
            "authors": [
                "George Budwell"
            ],
            "summary": "The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756902%2Fgrowth-trend.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.905476"
                }
            ],
            "overall_sentiment_score": 0.250693,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BEAM",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.27273",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.239476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.239476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EDIT",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "-0.025609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VERV",
                    "relevance_score": "0.136888",
                    "ticker_sentiment_score": "0.32749",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.239476",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRBU",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "-0.025609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NTLA",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.140565",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PRME",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "-0.025609",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36064531/fda-grants-second-conditional-approval-for-eli-lillys-rare-blood-cancer-drug",
            "time_published": "20231204T120627",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Friday, the FDA approved Eli Lilly and Co's LLY Jaypirca ( pirtobrutinib, 100 mg & 50 mg tablets ) for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma ( CLL/SLL ) who have received at least two prior lines of therapy.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/04/eli_lilly_corporate_center_indianapolis_indiana_usa.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.071608,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.436009",
                    "ticker_sentiment_score": "0.15249",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs - Roche Holding  ( OTC:RHHBF ) , Roche Holding  ( OTC:RHHVF ) , Roche Holding  ( OTC:RHHBY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36064233/roche-joins-bandwagon-to-challenge-novo-nordisk-eli-lilly-for-weight-loss-drugs",
            "time_published": "20231204T120428",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Roche Holding AG RHHBY has agreed to acquire a privately held obesity company Carmot Therapeutics, seeking to challenge the dominance of weight-loss drugs from Novo Nordisk A/S NVO and Eli Lilly And Co LLY.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/04/roche.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.24333,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.24258",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.24258",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023",
            "url": "https://www.prnewswire.com/news-releases/lilly-extends-tender-offer-to-acquire-point-biopharma-to-dec-15-2023-302003960.html",
            "time_published": "20231204T114500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Dec. 4, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares ( \"Shares\" ) of common stock of POINT Biopharma Global Inc. ( NASDAQ: PNT ) , for a purchase ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.999973"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.275127,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.448654",
                    "ticker_sentiment_score": "0.339011",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.033942",
                    "ticker_sentiment_score": "0.165381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CMSQF",
                    "relevance_score": "0.033942",
                    "ticker_sentiment_score": "0.18376",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.067823",
                    "ticker_sentiment_score": "0.064437",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics in race to rival Novo Nordisk's Ozempic",
            "url": "https://www.marketwatch.com/story/roche-strikes-3-1-billion-deal-to-buy-obesity-drug-maker-carmot-therapeutics-billion-in-race-to-rival-novo-nordisks-ozempic-6b88b8c9",
            "time_published": "20231204T104000",
            "authors": [
                "Louis Goss"
            ],
            "summary": "The race for weight-loss drugs stepped up Monday after Roche said it would buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion.",
            "banner_image": "https://images.mktw.net/im-740245/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.140301,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.105946",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.201018",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.132332",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.232996",
                    "ticker_sentiment_score": "0.219072",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.232996",
                    "ticker_sentiment_score": "-0.013105",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.117774",
                    "ticker_sentiment_score": "-0.072874",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pfizer  ( PFE )  Stock Down 5% as Obesity Drug Fails in Phase II",
            "url": "https://www.zacks.com/stock/news/2192689/pfizer-pfe-stock-down-5-as-obesity-drug-fails-in-phase-ii",
            "time_published": "20231204T103200",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The failure of the phase IIb study on danuglipron is a significant blow to Pfizer's (PFE) efforts to take a share of the growing market of GLP-1 drugs for treating obesity.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/82/41137.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.127847,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.08737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.170475",
                    "ticker_sentiment_score": "0.109247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.22595",
                    "ticker_sentiment_score": "0.229561",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.333257",
                    "ticker_sentiment_score": "-0.002375",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}